Pratik Choudhary, United Kingdom

University of Leicester Diabetes Research Centre
Professor Pratik Choudhary is Professor of Diabetes at the University of Leicester, having recently joined there after 15 years at King's College London. He is chair of the Diabetes Technology Network UK, and is also part of the EASD Post Graduate Education Committee. His academic and clinical interests are around different aspects that affect type 1 diabetes, including education ( through the UK DAFNE program), technology ( with research around insulin pumps and CGM) as well as psychology ( through the HARPdoc program) and transplantation. He has published a number of papers and international guidelines around the use of new technologies in diabetes, including closed loop systems. his consultative style that integrates education, technology and psychology.

Presenter of 8 Presentations

INDUSTRY SESSION

The Intersection of Flash Glucose Monitoring Technology and Real World Care in Persons with Diabetes: What Can New Trials Teach Us? And What are the Implications for Adopting CGM in the Covid Era and Beyond?

INDUSTRY SESSION

Real World Evidence Supporting Superior Glycemic Control with Flash Glucose Monitoring Across the Spectrum of Diabetes Care: Improvements in Time-in-Range and Other Diabetes-Related Health Metrics

INDUSTRY SESSION

Evolving needs in the connected era

ORAL PRESENTATION SESSION

GLYCEMIC MEASURES FOR 8,914 ADULT FREESTYLE LIBRE® USERS DURING ROUTINE CARE SEGMENTED BY AGE GROUP AND OBSERVED CHANGES DURING THE COVID PANDEMIC

Abstract

Background and Aims

We report for the first time normative glucose metrics for %TIR 3.9-10 mmol/L, %TBR <3.9 mmol/L and %TAR >10 mmol/L for adult FreeStyle Libre users in the UK within 4 defined age-groups and the impact of the COVID-19 pandemic on these over time.

Methods

Data was extracted from 8,914 LibreView® de-identified user accounts from adult users aged 18+ with ≥5 days of sensor readings in each month from January to June 2020. Age-group categories were based on self-reported age on LibreView accounts (18-25, 26-49, 50-64, 65+ yrs).

Results

Adult FreeStyle Libre users in this UK study report mean TIR above 51% and median TBR 4.2% or below. In January, prior to the pandemic, the 65+ age group had the highest %TIR (57.9%) while the 18-25 age group had the lowest (51.2%). Consensus targets >70% TIR and <4% TBR were achieved by 11.7% of users aged 65+ compared to 6.0% of those 18-25. Within each age group, TIR change was significant during the analysed months (p<0.001) by repeated measures ANOVA. Comparing January to June 2020, all age groups increased TIR, with those aged 65+ increasing the most (3.1%; p<0.001). The proportion of adults achieving both >70% TIR and <4% TBR targets increased to 15.9% for those 65+ years (p<0.001) and 9.1% for 18-25 (p<0.05).

table for attd 2021 uk covid abstract.jpg

Conclusions

During lockdown in the UK, the proportion of adults achieving TIR consensus targets increased among FreeStyle Libre users. The glucose metrics suggest an opportunity for even further improvement with continued CGM use.

Hide
PLENARY SESSION

Transplantation – managing partial pancreas function or managing the failing pancreas

INDUSTRY SESSION

The Complexities of Insulin Management

Moderator of 1 Session

INDUSTRY SESSION
Date
Wed, 02.06.2021
Session Type
INDUSTRY SESSION
Session Time
18:35 - 20:05
Room
Hall E
Session Description

Evolving Observational and Real World Data Around Sensor-Based CGM Across the Diabetes Treatment Spectrum - Industry Symposium Supported by Abbott Diabetes Care

Session description - Using international authorities on diabetes management and technology as faculty, this activity will focus on emerging digital, real time-, and sensor patch-based technologies for continuous monitoring of glucose levels, to improve drug interventions for persons with diabetes, minimize risks of hypoglycemia, maximize time in target range for blood glucose, and to optimize treatment interventions and drug titration and selection. The faculty will discuss the Intersection of flash glucose monitoring technology and real world application, and the Implications for adopting CGM in the Covid era and beyond.